BEMIPHARMA
ActiveSummary
BEMIPHARMA has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39,375 and a net result of -€179. Equity is shrinking by about 5.8% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.4% (very low).
Group and network
Connections & network
No directors read yet: 1 of 2 Gazette acts processed.